$GTCH As the adoption of artificial intelligence
Post# of 9961
$GTCH As the adoption of artificial intelligence (AI) and its adjacent technologies in the healthcare space increases, so too does its use cases within the sector. In a recent interview with Investorideas.com, Danny Rittman, the CTO of GBT Technologies Inc. (OTC Pink: GTCH) highlighted the way AI is being leveraged in GBT's own healthcare tech IP's, and in the healthcare and medicine domain more broadly.
"We've seen AI in healthcare develop rapidly in the past decade or so," Rittman said. "Major corporations, like IBM, Apple and others stepped in and introduced apparatuses like wearables, as well as AI systems in other forms. IBM was one of the first major players with Watson, which was and is still a huge project, providing analytics in the cancer domain and others."
GBT's intelligent health advisory system, codenamed Hippocrates, leverages the company's Avant! AI engine. Rittman explained Hippocrates and how it can be used as an assistant to physicians.
gtch-cto-discusse_1" rel="nofollow noopener noreferrer ugc" target="_blank">gtch-cto-discusse_1" rel="nofollow noopener noreferrer ugc" target="_blank">gtch-cto-discusse_1" rel="nofollow noopener noreferrer ugc" target="_blank">gtch-cto-discusse_1" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.spreaker.com/user/investorideas/ai-eye-podcast-gbt-otc-gtch-cto-discusse_1